Physiological monitoring of the complex multimorbid heart failure patient – diabetes and monitoring glucose control

por Seferović, Petar M, Jhund, Pardeep S
Publicado 2019

The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan

por Jhund, Pardeep S, McMurray, John J V
Publicado 2016

Joint modelling of longitudinal processes and time-to-event outcomes in heart failure: systematic review and exemplar examining the relationship between serum digoxin levels and mo...

por Field, Ryan J., Adamson, Carly, Jhund, Pardeep, Lewsey, Jim
Publicado 2023

Drug therapy for heart failure with reduced ejection fraction: what is the ‘right’ dose?

por Kondo, Toru, Jhund, Pardeep S., McMurray, John J.V.
Publicado 2022

The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context

por McMurray, John J V, Solomon, Scott D, Docherty, Kieran F, Jhund, Pardeep S
Publicado 2020

What can we learn from RELAX-AHF compared to previous AHF trials and what does the future hold?

por Cannon, Jane A, McKean, Andrew R, Jhund, Pardeep S, McMurray, John J V
Publicado 2015

Association is not causation: treatment effects cannot be estimated from observational data in heart failure

por Rush, Christopher J, Campbell, Ross T, Jhund, Pardeep S, Petrie, Mark C, McMurray, John J V
Publicado 2018

Heart failure and atrial flutter: a systematic review of current knowledge and practices

por Diamant, Michael J., Andrade, Jason G., Virani, Sean A., Jhund, Pardeep S., Petrie, Mark C., Hawkins, Nathaniel M.
Publicado 2021

Efficacy of implantable haemodynamic monitoring in heart failure across ranges of ejection fraction: a systematic review and meta-analysis

por Curtain, James P, Lee, Matthew M Y, McMurray, John JV, Gardner, Roy S, Petrie, Mark C, Jhund, Pardeep S
Publicado 2023

Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction

por Rørth, Rasmus, Dewan, Pooja, Kristensen, Søren Lund, Jhund, Pardeep S., Petrie, Mark C., Køber, Lars, McMurray, John J. V.
Publicado 2019

Within trial comparison of survival time projections from short‐term follow‐up with long‐term follow‐up findings

por Ferreira, João Pedro, Claggett, Brian L., Docherty, Kieran F., Jhund, Pardeep S., Zannad, Faiez, Solomon, Scott D., McMurray, John J.V.
Publicado 2022

Cost‐effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health‐economic analysis of DAPA‐HF

por McEwan, Phil, Darlington, Oliver, McMurray, John J.V., Jhund, Pardeep S., Docherty, Kieran F., Böhm, Michael, Petrie, Mark C., Bergenheim, Klas, Qin, Lei
Publicado 2020

Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland

por Lewsey, James, Jhund, Pardeep S, Gillies, Michelle, Chalmers, Jim WT, Redpath, Adam, Briggs, Andrew, Walters, Matthew, Langhorne, Peter, Capewell, Simon, McMurray, John JV, MacIntyre, Kate
Publicado 2010

Explaining trends in Scottish coronary heart disease mortality between 2000 and 2010 using IMPACT(SEC) model: retrospective analysis using routine data

por Hotchkiss, Joel W, Davies, Carolyn A, Dundas, Ruth, Hawkins, Nathaniel, Jhund, Pardeep S, Scholes, Shaun, Bajekal, Madhavi, O’Flaherty, Martin, Critchley, Julia, Leyland, Alastair H, Capewell, Simon
Publicado 2014

Resistance to antihypertensive treatment and long‐term risk: The Atherosclerosis Risk in Communities study

por Wijkman, Magnus O., Malachias, Marcus V.B., Claggett, Brian L., Cheng, Susan, Matsushita, Kunihiro, Shah, Amil M., Jhund, Pardeep S., Coresh, Josef, Solomon, Scott D., Vardeny, Orly
Publicado 2021

Eligibility for pharmacological therapies in heart failure with reduced ejection fraction: implications of the new Chronic Kidney Disease Epidemiology Collaboration creatinine equa...

por Butt, Jawad H., Adamson, Carly, Docherty, Kieran F., Vaduganathan, Muthiah, Solomon, Scott D., Anand, Inder S., Zannad, Faiez, Køber, Lars, Jhund, Pardeep S., McMurray, John J.V.
Publicado 2022

Efficacy of pulmonary artery pressure monitoring in patients with chronic heart failure: a meta-analysis of three randomized controlled trials

por Clephas, Pascal R D, Radhoe, Sumant P, Boersma, Eric, Gregson, John, Jhund, Pardeep S, Abraham, William T, McMurray, John J V, de Boer, Rudolf A, Brugts, Jasper J
Publicado 2023

Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS‐HF and RALES

por Yeoh, Su E., Dewan, Pooja, Serenelli, Matteo, Ferreira, João Pedro, Pitt, Bertram, Swedberg, Karl, van Veldhuisen, Dirk J., Zannad, Faiez, Jhund, Pardeep S., McMurray, John J.V.
Publicado 2021

Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction

por Serenelli, Matteo, Jackson, Alice, Dewan, Pooja, Jhund, Pardeep S., Petrie, Mark C., Rossignol, Patrick, Campo, Gianluca, Pitt, Bertram, Zannad, Faiez, Ferreira, João Pedro, McMurray, John J.V.
Publicado 2020

A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction

por Vaduganathan, Muthiah, Jhund, Pardeep S, Claggett, Brian L, Packer, Milton, Widimský, Jiri, Seferovic, Petar, Rizkala, Adel, Lefkowitz, Martin, Shi, Victor, McMurray, John J V, Solomon, Scott D
Publicado 2020